Non small cell lung cancer (NSCLC) xenografts as models for the prediction of response to tyrosine kinase inhibitors

被引：0
|
作者：
Fichtner, Iduna [1 ]
Rolff, Jana [1 ]
Soong, Richie [2 ]
Becker, Michael [1 ]
Lee, Sumarlin [2 ]
Sommer, Anette [3 ]
Merk, Johannes [4 ]
机构：
[1] Max Delbruck Ctr, Berlin 117548, Germany
[2] Natl Univ Singapore, Singapore, Singapore
[3] Bayer Schering Pharma AG, Berlin, Germany
[4] Lung Clin, Berlin, Germany
来源：
MOLECULAR CANCER THERAPEUTICS | 2007年 / 6卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3528S / 3528S
页数：1
相关论文
共 50 条
  • [1] Non small cell lung cancer xenografts as preclinical models for investigations with tyrosine kinase inhibitors
    Rolff, J.
    Merk, J.
    Lee, S.
    Soong, R.
    Becker, M.
    Sommer, A.
    Fichtner, I.
    [J]. EJC SUPPLEMENTS, 2007, 5 (08): : 32 - 32
  • [2] A systematic review of economic evaluations of tyrosine kinase inhibitors for non-small cell lung cancer (NSCLC)
    Byun, Joo-Young
    Park, Sun-Kyeong
    Ng, Boon Peng
    Liu, Yi-Shao
    Kim, Chae-Rin
    Park, Chanhyun
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2022, 23 (11) : 1247 - 1257
  • [3] Elucidating mechanisms of resistance to EGFR tyrosine kinase inhibitors in non-small cell lung cancer (NSCLC)
    Pao, William
    Miller, Vincent A.
    Kris, Mark G.
    Varmus, Harold E.
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 4 - 4
  • [4] Tyrosine kinase inhibitors in the management of non-small cell lung cancer
    Perol, M.
    Arpin, D.
    [J]. REVUE DES MALADIES RESPIRATOIRES, 2007, 24 (08) : S188 - S197
  • [5] Molecular predictors of response to tyrosine kinase inhibitors in patients with Non-Small-Cell Lung Cancer
    Murray, Samuel
    Karavasilis, Vasilios
    Bobos, Mattheos
    Razis, Evangelia
    Papadopoulos, Savvas
    Christodoulou, Christos
    Kosmidis, Paris
    Fountzilas, George
    [J]. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2012, 31
  • [6] Molecular predictors of response to tyrosine kinase inhibitors in patients with Non-Small-Cell Lung Cancer
    Samuel Murray
    Vasilios Karavasilis
    Mattheos Bobos
    Evangelia Razis
    Savvas Papadopoulos
    Christos Christodoulou
    Paris Kosmidis
    George Fountzilas
    [J]. Journal of Experimental & Clinical Cancer Research, 31
  • [7] Tyrosine kinase inhibitors and chemotherapy target different non-small cell lung cancer (NSCLC) patient populations
    Toschi, Luca
    Ligorio, Claudia
    Magrini, Elisabetta
    Bartolini, Stefania
    Finocchiaro, Giovanna
    Cancellieri, Alessandra
    Metro, Giulio
    Tallini, Giovanni
    Varella-Garcia, Marileila
    Cappuzzo, Federico
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : 219 - 219
  • [8] Developing of EGFR resistant mutations to Tyrosine Kinase Inhibitors (TKI) in Non-Small Cell Lung Cancer (NSCLC)
    Raez, L. E.
    Baca, Y.
    Nagasaka, M.
    Nieva, J.
    Mandani, H.
    Wanderwalde, A.
    Borghaei, H.
    Naban, C.
    Langer, C.
    Socinsky, M. A.
    Lopes, G.
    Khan, H.
    Wozniak, A.
    Carracedo, C.
    Liu, S.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S597 - S597
  • [9] Anaplastic lymphoma kinase tyrosine kinase inhibitors in non-small cell lung cancer
    Vavala, Tiziana
    Mariniello, Annapaola
    Novello, Silvia
    [J]. TRANSLATIONAL CANCER RESEARCH, 2019, 8 : S48 - S54
  • [10] Clinical and molecular predictors of response to EGFR tyrosine kinase inhibitors in non-small cell lung cancer
    Rouge, Thibault de La Motte
    Valent, Alexander
    Ambrosetti, Damien
    Vielh, Philippe
    Lacroix, Ludovic
    [J]. ANNALES DE PATHOLOGIE, 2007, 27 (05) : 353 - 363
12345